玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

GNE-493

    
98%

GNE-493

源葉(MedMol)
S81768 一鍵復制產品信息
1033735-94-2
C17H20N6O2S
372.4447
HMS3244E04; GNE-493; HMS3244F03; UNII-0L843LS9YK; HMS3244E03;
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S81768-1mg 98% ¥240.00 10 - - -
S81768-5mg 98% ¥380.00 6 - - -
S81768-10mg 98% ¥610.00 6 - - -
S81768-25mg 98% ¥1070.00 5 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

GNE-493 is a potent, selective, and orally available dual pan-PI3-kinase/mTOR inhibitor with IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR.

產品描述: GNE-493 is a potent, selective, and orally available dual pan-PI3-kinase/mTOR inhibitor with IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR.
靶點: PI3Kα:3.4 nM (IC50);PI3Kβ:12 nM (IC50);PI3Kδ:16 nM (IC50);PI3Kγ:16 nM (IC50);mTOR:30 nM (IC50);PI3K;?mTOR
體外研究: GNE-493 is a low molecular weight, potent dual inhibitor of pan-PI3 kinases and mTOR. GNE-493 displays approximately equipotent inhibition of Class I PI3K isoforms, is submitted for screening in a 142 kinase panel provided by Invitrogen’s SelectScreen service. Of these kinases, only three are subject to greater than 50% inhibition by GNE-493, and none are inhibited greater than 80% when tested at 1 μM. Subsequently measured IC50s demonstrated that GNE-493 is more than 100-fold selective for PI3Kα over these three unrelated kinases (Aurora A IC50>10 μM, MLK1 IC50=591 nM and SYK IC50=371 nM)
體內研究: To confirm and compare in vivo efficacy, GNE-493 is examined in the human MCF7.1 breast cancer xenograft model that harbors a PI3Kα activating mutation. Mice bearing xenografts are dosed orally once daily with 10 mg/kg of GNE-493 for 21 continuous days. Similar to observations made in the PC3 prostate cancer xenograft model, 10 mg/kg of GNE-493 results in 73% tumor growth inhibition at day 21 when compared to vehicle control animals. When achieving comparable levels of drug exposure, GNE-493 shows a similar suppression of the PI3K pathway and consequently, a similar efficacy profile against MCF7.1 breast tumors
參考文獻: 1. Sutherlin DP, et al. Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer. J Med Chem. 2010 Feb 11;53(3):1086-97.
溶解性: soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.685 ml 13.425 ml 26.85 ml
5 mM 0.537 ml 2.685 ml 5.37 ml
10 mM 0.268 ml 1.342 ml 2.685 ml
50 mM 0.054 ml 0.268 ml 0.537 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關產品

主站蜘蛛池模板: 桑日县| 三门峡市| 晋宁县| 瑞昌市| 驻马店市| 泸水县| 肥城市| 天峻县| 金寨县| 阜宁县| 宝兴县| 拉孜县| 琼海市| 黄石市| 龙南县| 泽库县| 余干县| 银川市| 赣榆县| 措美县| 阳高县| 东明县| 星子县| 合川市| 家居| 沅江市| 禄丰县| 苗栗市| 宁晋县| 仙居县| 汶上县| 舟曲县| 纳雍县| 丁青县| 渝中区| 通渭县| 北京市| 晋城| 安达市| 南通市| 周宁县|